Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: New treatments for mantle cell lymphoma and B-cell lymphoma, July 2023

Publish date: June 29, 2023

• Read More

Clinical Edge Journal Scan

Meta-analysis explores the best first-line immunotherapy regimens for transplant-ineligible MCL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

Obinutuzumab+bendamustine a potent treatment option for relapsed or refractory CLL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

Front-line BTK inhibitor+anti-CD20 antibody tops chemoimmunotherapy in CLL, reveals meta-analysis

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

R-High-CHOP/CHASER/LEED with auto-PBSCT provides favorable long-term survival outcomes in untreated MCL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

Tafasitamab+lenalidomide provides survival benefit over pola-BR and R2 in relapsed or refractory DLBCL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

First-line rituximab+bendamustine+cytarabine combination shows long-term efficacy in the elderly with MCL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

First-line fixed-duration ibrutinib+venetoclax shows promise against high-risk CLL

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

Depression or anxiety shortens the survival of DLBCL patients

Publish date: June 20, 2023

• Read More

Clinical Edge Journal Scan

Phase 3 data favor axi-cel over standard care in high-risk large B-cell lymphoma

Publish date: June 20, 2023

• Read More

Pages

• 1
• 2
• 3
• 4
• 5
• 6
• last »